These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 16101753)
1. Transcriptional involvement of protein kinase C-alpha isozyme in amphetamine-mediated appetite suppression. Hsieh YS; Yang SF; Chiou HL; Kuo DY Eur J Neurosci; 2005 Aug; 22(3):715-23. PubMed ID: 16101753 [TBL] [Abstract][Full Text] [Related]
2. Roles of protein kinase Calpha isozyme in the regulation of oxidative stress and neuropeptide Y gene expression in phenylpropanolamine-mediated appetite suppression. Kuo DY; Yang SF; Chu SC; Chen CH; Hsieh YS J Neurochem; 2009 Mar; 108(6):1495-506. PubMed ID: 19183253 [TBL] [Abstract][Full Text] [Related]
3. Amphetamine-evoked changes of oxidative stress and neuropeptide Y gene expression in hypothalamus: regulation by the protein kinase C-delta signaling. Kuo DY; Yang SF; Chu SC; Chu SC; Chen CH; Hsieh YS Chem Biol Interact; 2009 Jul; 180(2):193-201. PubMed ID: 19497417 [TBL] [Abstract][Full Text] [Related]
4. Intracerebral administration of protein kinase A or cAMP response element-binding protein antisense oligonucleotide can modulate amphetamine-mediated appetite suppression in free-moving rats. Hsieh YS; Yang SF; Kuo DY Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E123-31. PubMed ID: 16896163 [TBL] [Abstract][Full Text] [Related]
5. Knocking down the transcript of protein kinase C-lambda modulates hypothalamic glutathione peroxidase, melanocortin receptor and neuropeptide Y gene expression in amphetamine-treated rats. Hsieh YS; Yang SF; Chen PN; Chu SC; Chen CH; Kuo DY J Psychopharmacol; 2011 Jul; 25(7):982-94. PubMed ID: 20817751 [TBL] [Abstract][Full Text] [Related]
6. Interrupting activator protein-1 signaling in conscious rats can modify neuropeptide Y gene expression and feeding behavior of phenylpropanolamine. Hsieh YS; Yang SF; Chu SC; Kuo DY J Neurochem; 2008 Jan; 104(1):50-61. PubMed ID: 17868324 [TBL] [Abstract][Full Text] [Related]
7. Involvement of hypothalamic neuropeptide Y in regulating the amphetamine-induced appetite suppression in streptozotocin diabetic rats. Kuo DY Regul Pept; 2005 Apr; 127(1-3):19-26. PubMed ID: 15680466 [TBL] [Abstract][Full Text] [Related]
8. Activations of c-fos/c-jun signaling are involved in the modulation of hypothalamic superoxide dismutase (SOD) and neuropeptide Y (NPY) gene expression in amphetamine-mediated appetite suppression. Hsieh YS; Yang SF; Chiou HL; Kuo DY Toxicol Appl Pharmacol; 2006 Apr; 212(2):99-109. PubMed ID: 16084549 [TBL] [Abstract][Full Text] [Related]
9. Transcript of protein kinase A knock-down modulates feeding behavior and neuropeptide Y gene expression in phenylpropanolamine-treated rats. Hsieh YS; Yang SF; Chu SC; Kuo DY Physiol Genomics; 2007 Oct; 31(2):306-14. PubMed ID: 17684035 [TBL] [Abstract][Full Text] [Related]
10. Amphetamine, an appetite suppressant, decreases neuropeptide Y immunoreactivity in rat hypothalamic paraventriculum. Hsieh YS; Yang SF; Kuo DY Regul Pept; 2005 Apr; 127(1-3):169-76. PubMed ID: 15680483 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical and genomic evidence for the involvement of hypothalamic neuropeptide Y (NPY) in phenylpropranolamine-mediated appetite suppression. Hsieh YS; Hsu JD; Yang SF; Kuo DY Peptides; 2004 Dec; 25(12):2155-61. PubMed ID: 15572205 [TBL] [Abstract][Full Text] [Related]
12. Involvement of neuropeptide Y Y1 receptor in the regulation of amphetamine-mediated appetite suppression. Kuo DY; Chen PN; Yu CH; Kuo MH; Hsieh YS; Chu SC Neuropharmacology; 2012 Oct; 63(5):842-50. PubMed ID: 22732442 [TBL] [Abstract][Full Text] [Related]
14. Involvement of oxidative stress in the regulation of NPY/CART-mediated appetite control in amphetamine-treated rats. Hsieh YS; Chen PN; Yu CH; Chen CH; Tsai TT; Kuo DY Neurotoxicology; 2015 May; 48():131-41. PubMed ID: 25825358 [TBL] [Abstract][Full Text] [Related]
15. Transcriptional interruption of cAMP response element binding protein modulates superoxide dismutase and neuropeptide Y-mediated feeding behavior in freely moving rats. Hsieh YS; Yang SF; Chu SC; Ho YJ; Kuo CS; Kuo DY J Neurochem; 2008 May; 105(4):1438-49. PubMed ID: 18221372 [TBL] [Abstract][Full Text] [Related]
16. Role of hypothalamic leptin-LepRb signaling in NPY-CART-mediated appetite suppression in amphetamine-treated rats. Chu SC; Chen PN; Chen JR; Yu CH; Hsieh YS; Kuo DY Horm Behav; 2018 Feb; 98():173-182. PubMed ID: 29307696 [TBL] [Abstract][Full Text] [Related]
17. Roles of central catecholamine and hypothalamic neuropeptide Y genome in the development of tolerance to phenylpropanolamine-mediated appetite suppression. Hsieh YS; Yang SF; Chiou HL; Kuo DY Behav Neurosci; 2007 Oct; 121(5):933-40. PubMed ID: 17907825 [TBL] [Abstract][Full Text] [Related]
18. Further evidence for the mediation of both subtypes of dopamine D1/D2 receptors and cerebral neuropeptide Y (NPY) in amphetamine-induced appetite suppression. Kuo DY Behav Brain Res; 2003 Dec; 147(1-2):149-55. PubMed ID: 14659580 [TBL] [Abstract][Full Text] [Related]
19. Both neuropeptide Y knockdown and Y1 receptor inhibition modulate CART-mediated appetite control. Chu SC; Chen PN; Ho YJ; Yu CH; Hsieh YS; Kuo DY Horm Behav; 2015 Jan; 67():38-47. PubMed ID: 25461972 [TBL] [Abstract][Full Text] [Related]
20. Opposing effects of phorbol-12-myristate-13-acetate, an activator of protein kinase C, on the signaling of structurally related human dopamine D1 and D5 receptors. Jackson A; Sedaghat K; Minerds K; James C; Tiberi M J Neurochem; 2005 Dec; 95(5):1387-400. PubMed ID: 16313517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]